All News

The FDA issued an EUA for the investigational antibody cocktail casirivimab and imdevimab for the treatment of mild-to-moderate COVID-19 in high risk patients.

The AstraZeneca/Oxford vaccine candidate showed 90% efficacy in one dosing regimen; 62% in a second; and an average efficacy rate of 70%.

Prepare patients for a safe Thanksgiving with key CDC-based recommendations including alternative Thanksgiving activities, steps to take if exposed to COVID-19, and more.

US confirmed cases of COVID-19 have surpassed 12 million; global cases have reached 58 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Global confirmed cases of COVID-19 have surpassed 57 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Americans with obesity and overweight are at greater risk for more severe COVID-19. Clinicians can support them best by asking how they can help.

Ensure your patients have a fun and safe COVID-19 Thanksgiving holiday with these quick CDC-based tips.

Global confirmed cases of COVID-19 have surpassed 56 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

For the first time, patients at suspected risk of COVID-19 can test themselves at home and see results within 30 minutes.

Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.

Increasing baseline FeNo levels were associated with reduced exacerbation and greater lung function improvement in dupilumab-vs-placebo-treated patients.

Increased blood eosinophil counts and IgE levels are associated with higher exacerbation rates in patients with severe asthma, according to new research presented at ACAAI 2020.

US confirmed cases of COVID-19 have surpassed 11 million; global cases have reached 55 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.

Distinguishing asthma and COPD can at times be problematic and the asthma-COPD overlap picture is even less clear. Check your recall of GINA/GOLD guidelines on all 3.

Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.

AHA 2020: Daily supplementation with 2000 IU of vitamin D3/day and/or 840 mg omega-3 fatty acids/day did not reduce or increase risk of incident atrial fibrillation.

Telemedicine use has increased significantly since COVID-19 began and while not new to all patients and providers, can pose unique challenges to care for older adults.